|
|
||||||||


*
Department of Biological Sciences, Mississippi State University, Mississippi State, MS 39762; and
Immunotoxicology Branch, National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711
Although reductionist experimental designs are excellent for identifying cells, molecules, or functions involved in resistance to particular microbes or cancer cells, they do not provide an integrated, quantitative view of immune function. In the present study, mice were treated with either dexamethasone (DEX) or cyclosporin A (CyA), and immune function and host resistance were evaluated. Multivariate statistical methods were used to describe the relative importance of a broad range of immunological parameters for host resistance in mice treated with various dosages of DEX. Multiple regression and logistic regression analysis indicated that changes in 24 immunological parameters explained a substantial portion of the changes in resistance to B16F10 tumor cells or streptococcus group B. However, at least 40% of the change in host resistance remained unexplained. DEX at all dosages substantially suppressed numerous relevant immunological parameters, but significantly decreased resistance to Listeria monocytogenes only at the highest dosage. In contrast, CyA substantially decreased resistance to L. monocytogenes at dosages that caused relatively minor suppression of just a few immunological parameters (unfortunately, CyA data and host resistance data for L. monocytogenes were not suitable for multivariate analysis). These results illustrate that mathematical models can be used to explain changes in host resistance on the basis of changes in immune parameters, and that moderate changes in relevant immunological parameters may not produce the types of changes in host resistance expected on the basis of results from reductionist experimental designs.
This article has been cited by other articles:
![]() |
W. G. Jaoko, E. Michael, D. W. Meyrowitsch, B. B. A. Estambale, M. N. Malecela, and P. E. Simonsen Immunoepidemiology of Wuchereria bancrofti Infection: Parasite Transmission Intensity, Filaria-Specific Antibodies, and Host Immunity in Two East African Communities Infect. Immun., December 1, 2007; 75(12): 5651 - 5662. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gleeson Immune function in sport and exercise J Appl Physiol, August 1, 2007; 103(2): 693 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ask, E. H. van der Waaij, E. J. Glass, and S. C. Bishop Modeling Immunocompetence Development and Immunoresponsiveness to Challenge in Chicks Poult. Sci., July 1, 2007; 86(7): 1336 - 1350. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D Matson, A. A Cohen, K. C Klasing, R. E Ricklefs, and A. Scheuerlein No simple answers for ecological immunology: relationships among immune indices at the individual level break down at the species level in waterfowl Proc R Soc B, April 7, 2006; 273(1588): 815 - 822. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Adamo and R. J. Spiteri Female choice for male immunocompetence: when is it worth it? Behav. Ecol., September 1, 2005; 16(5): 871 - 879. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Irons, P. Pinge-Filho, and K. L. Fritsche Dietary (n-3) Polyunsaturated Fatty Acids Do Not Affect the In Vivo Development and Function of Listeria-Specific CD4+ and CD8+ Effector and Memory/Effector T Cells in Mice J. Nutr., May 1, 2005; 135(5): 1151 - 1156. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Germolec, A. Nyska, M. Kashon, C. F. Kuper, C. Portier, C. Kommineni, K. A. Johnson, and M. I. Luster Extended Histopathology in Immunotoxicity Testing: Interlaboratory Validation Studies Toxicol. Sci., March 1, 2004; 78(1): 107 - 115. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |